lumi tirzepatide meds GLP-1 Weight Loss Starter Bundle April Special: GLP-1 Weight Loss

Tirzepatide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Tirzepatide is the active ingredient in Mounjaro and Zepbound Tirzepatide vs Semaglutide: Greater weight loss with tirzepatide as seen in clinical trials: 21.1% average weight reduction with tirzepatide 10-15% average weight reduction with semaglutide Less side effects reported with tirzepatide Less risk of hypoglycemia with tirzepatide How it works: Targets areas in the brain that suppresses appetite and reduces cravings Delays digestion and stomach emptying leaving you feeling fuller for a longer period of time, more satisfied with smaller meals and smaller portions leading to weight loss With it's combined positive benefits to blood pressure, cholesterol, and blood sugar, Tirzepatide positively impacts your cardiovascular health and decreases your risk for heart disease.

It functions by suppressing hunger and slowing down food digestion, which may result in weight loss due to lower food intake

At what point should I consider switching to a different medication

This entity comprises NAFL and NASH, the latter being its progressive form and affecting about 1020% of patients

Other GLP-1 drugs start to come along